US Pharm. 2011;36(11):56.
The Generic Pharmaceutical Association (GPhA) released an independent analysis showing that the use of generic prescription drugs in the United States has saved consumers and the health care system $931 billion from 2001 to 2010. The analysis, conducted for GPhA by the IMS Institute for Healthcare Informatics and IMS Health, shows that in just 2010 generic drug use generated nearly $158 billion in savings.
“These findings could not have come at a more critical time,” said Ralph G. Neas, GPhA president and CEO. “The analysis shows beyond doubt that savings achieved through the use of safe and effective generics deliver a huge win to consumers looking to hold down their health care costs. Moreover, the savings provide a winning solution to those in Washington trying to address the sustainability of the nation's health care system, as well as the national economy.”
